Theriva Biologics logo

Theriva Biologics Share Price Today

(NASDAQ: TOVX)

Theriva Biologics share price is $1.35 & ₹117.41 as on 6 Mar 2025, 2.30 'hrs' IST

$1.35

0.05

(3.85%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Theriva Biologics share price in Dollar and Rupees. Guide to invest in Theriva Biologics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Theriva Biologics, along with analyst recommendations, forecasts, and comprehensive financials.

Theriva Biologics share price movements

  • Today's Low: $1.31
    Today's High: $1.36

    Day's Volatility :3.98%

  • 52 Weeks Low: $1.14
    52 Weeks High: $17.11

    52 Weeks Volatility :93.34%

Theriva Biologics (TOVX) Returns

PeriodTheriva Biologics IncIndex (Russel 2000)
3 Months
0.78%
0.0%
6 Months
-59.63%
0.0%
1 Year
-89.17%
0.0%
3 Years
-94.95%
-11.6%

Theriva Biologics (TOVX) Key Statistics

in dollars & INR

Previous Close
$1.3
Open
$1.31
Today's High
$1.36
Today's Low
$1.3059
Market Capitalization
$3.6M
Today's Volume
$2.1K
52 Week High
$17.1125
52 Week Low
$1.14
Revenue TTM
$0.0
EBITDA
$-20.1M
Earnings Per Share (EPS)
$-31.85
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-77.91%

How to invest in Theriva Biologics Stock (TOVX) from India?

It is very easy for Indian residents to invest directly in Theriva Biologics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Theriva Biologics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Theriva Biologics or TOVX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Theriva Biologics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Theriva Biologics shares which would translate to 0.644 fractional shares of Theriva Biologics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Theriva Biologics, in just a few clicks!

Returns in Theriva Biologics (TOVX) for Indian investors in Rupees

The Theriva Biologics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Theriva Biologics investment value today

Current value as on today

₹16,213

Returns

₹83,787

(-83.79%)

Returns from Theriva Biologics Stock

₹88,750 (-88.75%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Theriva Biologics (TOVX)

-77%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Theriva Biologics Stock from India on INDmoney has decreased by -77% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Theriva Biologics

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Theriva Biologics(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Theriva Biologics Stock (TOVX)

What analysts predicted

Upside of 344.44%

Target:

$6.00

Current:

$1.35

Insights on Theriva Biologics Stock (Ticker Symbol: TOVX)

  • Price Movement

    In the last 6 months, TOVX stock has moved down by -59.6%
  • TOVX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 151.8%

Theriva Biologics Technicals Summary

Sell

Neutral

Buy

Theriva Biologics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Theriva Biologics (TOVX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Theriva Biologics Inc logo
8.33%
-59.63%
-89.17%
-94.95%
-94.95%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Theriva Biologics Inc logo
NA
NA
NA
0.0
-0.78
-0.25
NA
9.41
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Theriva Biologics Inc logo
Buy
$3.6M
-94.95%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Theriva Biologics

Theriva Biologics, Inc., a clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States. The company's lead product candidate is VCN-01, a clinical stage oncolytic human adenovirus that is in a Phase 2 clinical study for the treatment of pancreatic cancer; a Phase 1 clinical study for the treatment of retinalblastoma; a Phase 1 clinical study for the treatment of head and neck squamous cell carcinoma; and a Phase 1 clinical study for the treatment of solid tumors. It also develops VCN-11 for treating solid tumors; SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage to prevent overgrowth and infection by pathogenic organisms, such Clostridioides difficile infection and vancomycin resistant Enterococci, and reducing the incidence and severity of acute graft-versus-host-disease (aGVHD) in allogeneic hematopoietic cell transplant recipients; and SYN-020, a recombinant oral formulation for the enzyme intestinal alkaline phosphatase to treat both local GI and systemic diseases. In addition, the company develops clinical stage products, such as SYN-006 to prevent aGVHD and infection by carbapenem resistant enterococci; and SYN-007 for preventing antibiotic associated diarrhea with oral ß-lactam antibiotics. It has collaboration agreements with The University of Texas at Austin, Catalan Institute of Oncology, Fundació Privada Institut d'Investigacio Biomedica de Bellvitge, Saint Joan De Déu, and Massachusetts General Hospital, as well as a clinical trial agreement with Washington University School of Medicine in St. Louis to conduct a Phase 1b/2a clinical trial of SYN-004. Theriva Biologics, Inc. is headquartered in Rockville, Maryland.
Organization
Theriva Biologics
Employees
22
CEO
Mr. Steven A. Shallcross CPA
Industry
Miscellaneous

Management People of Theriva Biologics

NameTitle
Mr. Steven A. Shallcross CPA
CEO, CFO, Treasurer, Corporate Secretary & Director
Dr. Vince Wacher Ph.D.
Head of Product & Corporate Development
Dr. Michael Kaleko M.D., Ph.D.
Senior Vice President of Research & Development
Dr. Ramon Alemany Ph.D.
Senior VP of Discovery & Chairman of Scientific Advisory Board

Important FAQs about investing in TOVX Stock from India :

What is Theriva Biologics share price today?

Theriva Biologics share price today stands at $1.35, Open: $1.31 ; Previous Close: $1.30 ; High: $1.36 ; Low: $1.31 ; 52 Week High: $17.11 ; 52 Week Low: $1.14.

The stock opens at $1.31, after a previous close of $1.30. The stock reached a daily high of $1.36 and a low of $1.31, with a 52-week high of $17.11 and a 52-week low of $1.14.

Can Indians buy Theriva Biologics shares?

Yes, Indians can invest in the Theriva Biologics (TOVX) from India.

With INDmoney, you can buy Theriva Biologics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Theriva Biologics at zero transaction cost.

How can I buy Theriva Biologics shares from India?

It is very easy to buy Theriva Biologics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Theriva Biologics (TOVX) be purchased?

Yes, you can buy fractional shares of Theriva Biologics with INDmoney app.

What are the documents required to start investing in Theriva Biologics stocks?

To start investing in Theriva Biologics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Theriva Biologics Stock (TOVX)?

Today’s highest price of Theriva Biologics (TOVX) is $1.36.

Today’s lowest price of Theriva Biologics (TOVX) is $1.31.

What is today's market capitalisation of Theriva Biologics?

Today's market capitalisation of Theriva Biologics TOVX is 3.6M

What is the 52 Week High and Low Range of Theriva Biologics Stock (TOVX)?

  • 52 Week High

    $17.11

  • 52 Week Low

    $1.14

What are the historical returns of Theriva Biologics (TOVX)?

  • 1 Month Returns

    8.33%

  • 3 Months Returns

    -59.63%

  • 1 Year Returns

    -89.17%

  • 5 Years Returns

    -94.95%

Who is the Chief Executive Officer (CEO) of Theriva Biologics ?

Mr. Steven A. Shallcross CPA is the current Chief Executive Officer (CEO) of Theriva Biologics.